Ganoderic acid A attenuated hepatic impairment by down-regulating the intracellular JAK2-STAT3 signaling pathway in induced mushroom poisoning

被引:0
作者
Xiao, Chenggen [1 ]
Huang, Guoqing [1 ]
Cao, Xiaoxia [2 ]
Li, Xiangmin [1 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Emergency Med, Changsha 410000, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Clin Nursing Teaching & Res Sect, Changsha 410000, Hunan, Peoples R China
来源
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH | 2024年 / 16卷 / 01期
基金
中国国家自然科学基金;
关键词
Ganoderma lucidum; Ganoderma lucidum A; mushroom poisoning; alpha-amatoxin; liver toxicity; ALPHA-AMANITIN; LUCIDUM; MICE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Mushroom poisoning is one of the most prominent public health problems. However, there is no special antidote so far. In the present study, we verified that Ganoderma lucidum may be an effective approach for treatment of acute mushroom poisoning. Methods: A retrospective study was performed within the past 20 years, we compiled information on the treatment of alpha-Amatoxin mushroom poisoning with Ganoderma lucidum by evaluating the mortality rate and liver function before and after treatment. Moreover, we explore the potential underlying mechanism of Ganoderma lucidum in the treatment of alpha-amanita poisoning in both in vivo animal experiments and in vitro cell experiments. Results: In our study, a total of 556 cases of mushroom poisoning were integrated over the past 20 years, the primary outcome was in-hospital mortality. Specificity, descriptive data of ALT, AST, BA and STB were evaluated for the effectiveness of protection to acute liver damage. From 1994 to 2002, there were 55 cases of mushroom poisoning in which 372 individuals were poisoned, 129 individuals died, with a mortality of 35%. Since 2002, after being treated with Ganoderma lucidum, surprisingly, the mortality decreased to 0%, and all the 184 patients were cured, the hepatic impairment improved significantly within 10 days. Based on a multivariate logistic regression analyses, after adjusting for age, gender and baseline clinical indicators, it was found that Ganoderma lucidum treatment was effective in reducing the morbidity (OR = 0.58), and Ganoderma lucidum treatment also showed an improvement in liver enzymes and in shortening the length of hospitalization significantly. Meanwhile, the main components of Ganoderma lucidum, Ganoderic acid A could significantly improve the survival rate and liver function in alpha-Amatoxin poisoned mice and may effectively inhibit the JAK2-STAT3 pathway, which could contribute to the detoxification in poisoned patients. Conclusion: Ganoderma lucidum is very effective in treating mushroom poisoning by alpha-amanita and is worth promoting.
引用
收藏
页码:295 / 303
页数:9
相关论文
共 36 条
  • [1] Ganoderma lucidum (Reishi) an edible mushroom; a comprehensive and critical review of its nutritional, cosmeceutical, mycochemical, pharmacological, clinical, and toxicological properties
    Ahmad, Rizwan
    Riaz, Muhammad
    Khan, Aslam
    Aljamea, Ahmed
    Algheryafi, Mohammad
    Sewaket, Deya
    Alqathama, Aljawharah
    [J]. PHYTOTHERAPY RESEARCH, 2021, 35 (11) : 6030 - 6062
  • [2] The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19
    Bagca, Bakiye Goker
    Avci, Cigir Biray
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2020, 54 : 51 - 61
  • [3] JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
    Banerjee, Shubhasree
    Biehl, Ann
    Gadina, Massimo
    Hasni, Sarfaraz
    Schwartz, Daniella M.
    [J]. DRUGS, 2017, 77 (05) : 521 - 546
  • [4] Wild-mushroom intoxication as a cause of rhabdomyolysis
    Bedry, R
    Baudrimont, I
    Deffieux, G
    Creppy, EE
    Pomies, JP
    Ragnaud, JM
    Dupon, M
    Neau, D
    Gabinski, C
    De Witte, S
    Chapalain, JC
    Godeau, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (11) : 798 - 802
  • [5] Ganoderma lucidum polysaccharides can induce human monocytic leukemia cells into dendritic cells with immuno-stimulatory function
    Chan, Wing Keung
    Cheung, Christopher Ching Hang
    Law, Helen Ka Wai
    Lau, Yu Lung
    Chan, Godfrey Chi Fung
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2008, 1 (1)
  • [6] Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota (vol 6, 7489, 2015)
    Chang, Chih-Jung
    Lin, Chuan-Sheng
    Lu, Chia-Chen
    Martel, Jan
    Ko, Yun-Fei
    Ojcius, David M.
    Tseng, Shun-Fu
    Wu, Tsung-Ru
    Chen, Yi-Yuan Margaret
    Young, John D.
    Lai, Hsin-Chih
    [J]. NATURE COMMUNICATIONS, 2017, 8
  • [7] Genome sequence of the model medicinal mushroom Ganoderma lucidum
    Chen, Shilin
    Xu, Jiang
    Liu, Chang
    Zhu, Yingjie
    Nelson, David R.
    Zhou, Shiguo
    Li, Chunfang
    Wang, Lizhi
    Guo, Xu
    Sun, Yongzhen
    Luo, Hongmei
    Li, Ying
    Song, Jingyuan
    Henrissat, Bernard
    Levasseur, Anthony
    Qian, Jun
    Li, Jianqin
    Luo, Xiang
    Shi, Linchun
    He, Liu
    Xiang, Li
    Xu, Xiaolan
    Niu, Yunyun
    Li, Qiushi
    Han, Mira V.
    Yan, Haixia
    Zhang, Jin
    Chen, Haimei
    Lv, Aiping
    Wang, Zhen
    Liu, Mingzhu
    Schwartz, David C.
    Sun, Chao
    [J]. NATURE COMMUNICATIONS, 2012, 3
  • [8] Energy disorders caused by mitochondrial dysfunction contribute to α-amatoxin-induced liver function damage and liver failure
    Chen Xiao
    Shao Bing
    Yu Chengmin
    Yao Qunmei
    Ma Peibin
    Li Haijiao
    Li Bin
    Sun Chengye
    [J]. TOXICOLOGY LETTERS, 2021, 336 : 68 - 79
  • [9] The cyclopeptide alpha -amatoxin induced hepatic injury via the mitochondrial apoptotic pathway associated with oxidative stress
    Chen, Xiao
    Shao, Bing
    Yu, Chengmin
    Yao, Qunmei
    Ma, Peibin
    Li, Haijiao
    Cai, Wenjian
    Fu, Hao
    Li, Bin
    Sun, Chengye
    [J]. PEPTIDES, 2020, 129
  • [10] JAK-STAT Targeting Offers Novel Therapeutic Opportunities in Sepsis
    Clere-Jehl, Raphael
    Mariotte, Alexandre
    Meziani, Ferhat
    Bahram, Seiamak
    Georgel, Philippe
    Helms, Julie
    [J]. TRENDS IN MOLECULAR MEDICINE, 2020, 26 (11) : 987 - 1002